Apoptotic cell death in the lactating mammary gland is enhanced by a folding variant of alpha-lactalbumin by Baltzer, A et al.
Research Article
Apoptotic cell death in the lactating mammary gland is
enhanced by a folding variant of a-lactalbumin
A. Baltzera, C. Svanborg b and R. Jaggi a,*
a Department of Clinical Research, University of Bern, Murtenstrasse 35, 3010 Bern (Switzerland), 
Fax: +41 31 632 32 97, e-mail: rolf.jaggi@dkf4.unibe.ch
b Lund University, Division of Microbiology, Immunology and Glycobiology, Lund, 223 62 (Sweden)
Received 30 January 2004; received after revision 5 March 2004; accepted 16 March 2004
Abstract. Apoptosis is essential to eliminate secretory
epithelial cells during the involution of the mammary
gland. The environmental regulation of this process is
however, poorly understood. This study tested the effect
of HAMLET (human a-lactalbumin made lethal to tumor
cells) on mammary cells. Plastic pellets containing
HAMLET were implanted into the fourth inguinal mam-
mary gland of lactating mice for 3 days. Exposure of
mammary tissue to HAMLET resulted in morphological
changes typical for apoptosis and in a stimulation of cas-
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pase-3 activity in alveolar epithelial cells near the HAM-
LET pellets but not more distant to the pellet or in con-
tralateral glands. The effect was specific for HAMLET
and no effects were observed when mammary glands
were exposed to native a-lactalbumin or fatty acid alone.
HAMLET also induced cell death in vitro in a mouse
mammary epithelial cell line. The results suggest that
HAMLET can mediate apoptotic cell death in mammary
gland tissue.
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The mammary gland develops during embryogenesis to a
mammary Anlage consisting of epithelium embedded in
adipocytes. A first burst of epithelial proliferation occurs
during puberty when an extensive ductal network is
formed. Pregnancy stimulates massive epithelial cell pro-
liferation and the formation of extended lobulo-alveolar
structures which terminally differentiate toward the end
of pregnancy. Continuous milk production by alveolar
cells is maintained during lactation via the suckling stim-
ulus exerted by the pups and elevated levels of glucocor-
ticoids and prolactin [1, 2]. Weaning causes involution of
the mammary gland, and the majority of secretory ep-
ithelial cells are removed by apoptotic cell death. The re-
maining structures are reorganized until a state resem-
bling the virgin gland is reached [3, 4]. Apoptosis of
mammary epithelial cells is regulated at the molecular
* Corresponding author.
level by cytochrome c release, proteolytic processing and
activation of several caspases, e.g. caspase-1, -3, -7, -8
and -9 [5, 6].
Involution occurs through programmed cell death in the
mammary gland, but the molecular events which initiate
or regulate apoptosis of secretory epithelial cells remain
unclear. Hormonal withdrawal, loss of mechanic stimula-
tion and resulting local tissue responses contribute and
overlap to safeguard this program [2, 7, 8]. For example,
expression of transforming growth factor (TGF)-b3 is
strongly induced in alveolar epithelial cells after weaning
before apoptosis is initiated [9]. The importance of TGF-
b3 on mammary epithelial cells was further documented
in transgenic mice by showing that overexpression in-
duced apoptosis during lactation while apoptosis was re-
duced but not fully absent in TGF-b3 knockout animals
[10]. Apoptosis in the mammary gland requires de novo
gene expression in mammary epithelial cells and imme-
diate early genes like fos and jun, members of transcrip-
tion factor AP-1, are up-regulated at the RNA and protein
level during involution leading to the expression of AP-1-
dependent genes [11]. Moreover, ATF4, another basic
leucine zipper-containing activating transcription factor
which can form heterodimers with Fos and Jun members,
seems to be important. Overexpression of ATF4 in trans-
genic animals was associated with up-regulation of
p21WAF1 and p27Kip1, with a stimulation of phosphoryla-
tion and nuclear translocation of Stat3 and an accelera-
tion of involution [12]. In fact, Stat3 is also activated dur-
ing normal involution and it may be a driving force dur-
ing apoptosis of mammary epithelial cells [13]. More
recently, leukemia inhibitory factor (LIF), which is in-
duced during early involution, was shown to stimulate
Stat3 phosphorylation [14].
HAMLET is a protein-lipid complex that induces cell
death selectively in tumor cells and immature cells, but
spares healthy cells. The protein component of HAMLET
is a-lactalbumin (a-LA), the most abundant protein in
human milk. a-LA is a globular, 14-kDa protein consist-
ing of four a helices, a triple-stranded anti-parallel 
b sheet and a high-affinity calcium-binding site [15] that
defines the native conformation of the protein [16]. In
HAMLET, a-LA is partially unfolded and thus the con-
version of a-LA to HAMLET involves the removal of
calcium. The lipid component in HAMLET is the C18:1,
9cis fatty acid (oleic acid) which stabilizes the complex
[17]. HAMLET shows broad activity against many dif-
ferent tumor cell lines in vitro, embryonal cells are mod-
erately sensitive, while healthy, differentiated cells are re-
sistant to the apoptosis-inducing effect. HAMLET acts by
gaining entry into the tumor cells and redistributing to the
nucleus, where it binds to histones and disrupts chro-
matin structures [18]. In the cytoplasm, HAMLET inter-
acts with mitochondria, causing the release of cy-
tochrome c followed by caspase activation [19].
Intuitively, molecules in human milk may influence the
involution of the mammary gland, but such mechanisms
have not been described. This study investigated whether
HAMLET may play a physiological role in the mammary
gland, as this is the major site of a-LA synthesis. Using
an in vivo model of mammary gland involution, we show
that HAMLET enhances apoptosis in alveolar epithelial
cells upon weaning. We conclude that HAMLET may act
as a homeostatic factor during the involution of the mam-
mary gland. 
Materials and methods
Preparation of HAMLET and HAMLET-releasing
ELVAX pellets
HAMLET was prepared from human milk as described
previously [20, 21]. HAMLET-releasing pellets were
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generated by mixing 40 mg of lyophilized HAMLET or
a-LA with 160 ml of methylene chloride containing 10%
ELVAX. The mixture was lyophilized and the resulting
large pellet was cut into pieces containing approx. 1, 2.5
or 5 mg of HAMLET. Cytotoxic HAMLET was formed
by incubating a-LA with oleic acid. Oleic acid-contain-
ing pellets were prepared by mixing the fatty acid with
10% ELVAX in methylene chloride and cutting the pellet
into smaller pieces after lyophilization. Pellets were
stored at –20°C until use. 
Animals, surgery and tissue preparation
Normal involution was induced in NMRI mice after 
5–7 days of lactation by removing the litter. Animals
were sacrificed at 3 days of involution and the fourth in-
guinal mammary glands were removed, fixed in 4%
paraformaldehyde (PFA) and embedded in paraffin.
For pellet implantation experiments, lactating mice were
anesthetized by injecting 50 ml/10 g of xylazine (0.5%
Rompun; Bayer, Leverkusen, Germany) and ketamine
(40 mg/ml Ketasol-100; Dr. E. Gräub AG, Bern, Switzer-
land). The skin was opened near the nipple of the fourth
inguinal gland by a short snip about 5 mm in length and
a single pellet containing 1, 2.5 or 5 mg HAMLET, 5 mg
a-LA, oleic acid or pure ELVAX was placed between the
surface of the glandular structure and the connective tis-
sue which spans the gland. Care was taken not to disturb
ductal structures of the gland. Lactation was continued by
returning the animals to their litter. Animals were sacri-
ficed 3 days later. The piece of gland containing the im-
planted pellet was fixed with 4% PFA and embedded
along with control material derived from more distant ar-
eas of the same gland and tissue from the contralateral
gland. A total of five animals were implanted with pellets
containing 1 mg of HAMLET, three animals with pellets
containing 2.5 mg and three animals with pellets contain-
ing 5 mg of HAMLET. As controls, six animals were im-
planted with pellets containing 5 mg a-LA, three animals
with oleic acid-containing pellets and five animals with
‘empty’ ELVAX pellets. Animal experiments were car-
ried out according to the ‘Ethical principles and guide-
lines for scientific experiments on animals’.
Cell culture, DAPI staining and preparation of cells
for immunocytochemistry
31D cells are a non-tumorigenic mouse mammary ep-
ithelial cell line derived from the mammary gland of mid-
pregnant Balb/c mice [22]. Cells were grown in DMEM
containing 10% fetal calf serum, 10 ng/ml epidermal
growth factor (Sigma, Buchs, Switzerland) and 5 mg/ml
insulin (Sigma) in an atmosphere containing 5% CO2 at
37°C. Before treatment, cells were washed twice with
phosphate-buffered saline (PBS) and incubated in serum-
free medium. HAMLET was freshly dissolved in DMEM
at 2 mg/ml and added to the cells. After incubating for 
24 h, the cells were trypsinized, washed with cold PBS,
fixed in 4% PFA for 10 min and stained with DAPI
(Roche Diagnostics, Basel, Switzerland) for 20 min at
room temperature. The percentage of cells with con-
densed chromatin was determined from at least 300 nu-
clei. Conditions (0 and 2 mg/ml HAMLET, 2 mg/ml
a-LA, 10 mg/ml cisplatin) were tested in at least three in-
dependent experiments.
For immunocytochemistry, approx. 50,000 native cells
(floating cells and trypsinized cells pooled) were plated
by cytospin (Cytospin2 centrifuge; Shandon, DAKO Di-
agnostics, Zug, Switzerland), fixed with 4% PFA for 
10 min and washed twice with cold PBS. Cells were
stored in 70% ethanol until immunocytochemistry or the
TUNEL reaction were performed.
Immunohistochemistry
Fixed cells or 6-mm-thick sections were treated with
0.6% H2O2 in methanol for 30 min to block endogenous
peroxidases, incubated with normal goat serum for
30 min (Kirkegaard and Perry, Socochim, Lausanne,
Switzerland) and then overnight with anti-active caspase-
3 (CM1) antibody [23] (PAbCM1, rabbit polyclonal;
Pharmingen, Becton Dickinson, Basel, Switzerland) at a
dilution of 1:2000 in normal goat serum at 4°C. Detec-
tion of antigen-antibody complexes was performed with
AEC (Envision System; DAKO, Glostrup, Denmark),
cells or sections were briefly counterstained with hema-
toxylin and covered with Aquatex (Merck, Grogg-
Chemie, Stettlen-Deisswil, Switzerland). Pictures were
taken with a DXM 1200 Nikon digital camera on a Nikon
Eclipse 800 microscope.
TUNEL reaction
Fixed cells or 6-mm-thick sections were incubated with
1.2 mg/ml proteinase K (Roche) for 10 min at 21°C and
then with terminal transferase (Roche) and digoxigenin-
11-dUTP (DIG; Roche) at 37°C for 40 min. DIG was de-
tected with anti-DIG-AP (Roche) at 1:2000 followed by a
reaction with NBT (Roche) and BCIP (Roche). After
brief counterstaining with hematoxylin, cells or sections
were covered with Aquatex (Merck) and photographed.
Results
Involution of the mouse mammary gland in response
to weaning
Mammary gland involution was induced in mice by re-
moving the litter after 5–7 days of lactation, starting
within 1 or 2 days and reaching a maximum after about 3
days. An initial engorgement is provoked by the accumu-
lation of milk in alveolar structures of the gland, but after
about 3 days post-weaning, milk is resorbed, alveolar
structures collapse and secretory epithelial cells die by an
apoptosis-like mechanism which was characterized by
morphology, caspase-3 activation and TUNEL staining
(data not shown). Apoptotic cells are rapidly phagocy-
tosed by lymphocytes or neighboring cells and disappear
from the gland. As a consequence, a relatively small frac-
tion of dying cells is observed at any stage of involution
(less than 3%). A similar sequence of events was previ-
ously shown in other mouse strains [4, 11, 24].
Processing of procaspase-3 and fragmentation of
nuclear DNA in lactating mammary glands after
exposure to HAMLET
The parameters of cell death and involution of the mam-
mary gland were studied after exposure to HAMLET, us-
ing native a-LA or oleic acid as controls. ELVAX plastic
pellets containing 5 mg HAMLET were implanted into
the fourth inguinal mammary gland of lactating mice
close to the prominent lymph node. Care was taken not to
disrupt lobular structures of the gland since this would
block milk removal from areas distal to the site of im-
plantation. Animals were sacrificed 3 days after implan-
tation and glands containing the pellet were removed  as
a whole. The pellet was localized visually and the area of
the gland containing the pellet was fixed, embedded in
paraffin and stained with hematoxylin and eosin. A col-
lapse of alveolar structures (fig. 1A) and an appearance
of apoptotic bodies (fig. 1A, inset) was observed in
glands exposed to HAMLET but no signs of regression
were observed more distant to the pellet (fig. 1B) or in
contralateral glands (not shown). Glands exposed to 
a-LA (fig. 1C), oleic acid (fig. 1D) or to untreated 
ELVAX pellets (fig. 1E) were similar to normal glands
during lactation. 
Caspase-3 activation in response to HAMLET was exam-
ined with the CM1 antibody. Staining was observed in
numerous alveolar epithelial cells in the immediate vicin-
ity of the pellet (fig. 2A) but not in cells located more dis-
tant to the pellet (fig. 2B) or in contralateral glands (not
shown). There was no evidence of caspase-3 activation
after implantation of a-LA (fig. 2C), oleic acid (fig. 2D)
or untreated ELVAX pellets (fig. 2E). A diffuse staining
in the immediate vicinity of the implanted pellets was
seen in some glands. This staining was most likely gener-
ated by stromal cells or infiltrating lymphocytes and re-
flects a local immune response after surgery.
Fragmentation of chromosomal DNA was studied by the
TUNEL assay. TUNEL staining was observed in secre-
tory epithelial cells exposed to pellets containing 5 mg
HAMLET (fig. 3A) within a few hundred micrometers of
the pellet. More distant to the pellet, no TUNEL-positive
cells were observed (data not shown). The effect was con-
centration dependent, as shown by a weaker response
with pellets containing 1 mg HAMLET (fig. 3B). No re-
action was observed in tissues exposed to a-LA (fig. 3C),
oleic acid (fig. 3D) or untreated pellets (fig. 3E). Again,
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Figure 1. Morphological changes in luminal epithelial cells in the vicinity of plastic pellets. ELVAX pellets containing 5 mg HAMLET 
(A, B), 5 mg inactive a-LA (C), oleic acid (D) or an ‘empty’ pellet (E) were implanted into the fourth inguinal mammary gland of lactat-
ing NMRI mice 5–7 days after parturition. Lactation was continued and mammary glands were removed 3 days later and pellet-contain-
ing pieces of the gland were fixed, embedded and cut into 6-mm-thick sections. Sections were stained with hematoxylin and eosin. B rep-
resents a region of the same section as shown in A but located more distant to the pellet. Each condition was tested in several animals 
and shown are representative pictures (see Material and methods for more details). The position of the pellet is indicated (p). The bar rep-
resents 50 mm. Insets in A show apoptotic cells at higher magnification.
Figure 2. Evaluation of processing of procaspase-3 in response to HAMLET-releasing pellets. ELVAX pellets containing 5 mg of HAM-
LET (A, B), 5 mg of inactive a-LA (C), oleic acid (D) or an ‘empty’ pellet (E) were implanted into the fourth inguinal mammary gland of
lactating NMRI mice 5–7 days after parturition. Lactation was continued and mammary glands were removed 3 days later and pellet-
containing pieces of each gland were fixed, embedded and cut into 6-mm-thick sections and processed for CM1 staining. B represents a 
region of the same section as in A but located more distant to the pellet. Several animals were tested for each experimental condition and
similar results were obtained (see Material and methods for more details). The bar represents 50 mm.
a local, most likely immunological, reaction occurred in
the immediate proximity of HAMLET-releasing pellets
and some of these infiltrating lymphocytes or stromal
cells were TUNEL positive. This non-specific reaction
was independent of the type of pellet implanted.
These results suggest that HAMLET induces a local re-
gression of alveolar structures, an induction of caspase-3-
like activity and a fragmentation of chromosomal DNA.
The same changes occur in the post-lactational mammary
gland during normal involution. The frequency of apop-
totic figures in the vicinity of HAMLET-containing pel-
lets was similar to that in normal involution (data not
shown).
Our observations strongly suggest that HAMLET stimu-
lates a regression of epithelial structures and an apoptotic
cell death of secretory epithelial cells in the lactating
mammary gland in vivo.
HAMLET induces apoptotic cell death in
non-transformed mouse mammary epithelial cells
The 31D cell line was originally cloned from IM-2, a
mixed cell culture of epithelial and mesenchymal cells
derived from the fourth inguinal gland of mid-pregnant
mice [22]. The 31D cells have an epithelial phenotype
and have retained some of their original physiological
properties: e.g. they can be stimulated with lactogenic
hormones (prolactin, glucocorticoids, insulin) to synthe-
size milk proteins like b-casein [25]. In this study, the ef-
fect of HAMLET on chromatin was examined. Exponen-
tially growing cells were treated with HAMLET for 24 h
and condensed chromatin was visualized by DAPI stain-
ing. Cells were treated with increasing concentrations of
HAMLET or with cisplatin (CP) as a positive control.
HAMLET caused a dose-dependent response and at 
2 mg/ml, almost 20% of the cells became apoptotic
within 24 h of treatment. In comparison, about 42% of all
cells died after 24 h of treatment with 10 mg/ml cisplatin
(fig. 4A). The 31D cells were insensitive to native a-LA,
and confluent cell layers did not respond to HAMLET or
cisplatin (fig. 4A). 
Caspase-3 activation was quantified as the fraction of
CM1-positive cells. HAMLET caused a 4.5-fold and CP
a 10-fold increase in caspase-3 reactivity compared to
untreated cells (fig. 4B, panels a, b and c). HAMLET
and CP were also shown to stimulate nuclear DNA frag-
mentation by 3- and 8-fold, respectively (fig. 4B, panels
d, e and f). Spontaneous cell death in untreated control
cells was rare (0.7 ± 0.2%; fig. 4A) and cells were neg-
ative after CM1 staining (fig. 4B, panel c) or TUNEL la-
beling (fig. 4B, panel f). The fact that confluent cells are
highly resistant to cell death implies that apoptosis by
HAMLET (and CP) is dependent on factors that are only
present or active in proliferating cells and not in conflu-
ent cells.
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Figure 3. Fragmentation of chromosomal DNA in the mammary gland after exposure to HAMLET. Pellets containing 5 (A) or 1 (B) mg
HAMLET, 5 mg of a-LA (C), oleic acid (D) or an ‘empty’ pellet (E) were implanted into the fourth inguinal mammary gland of lactating
animals. Pellet-containing areas of the gland were removed 3 days later, fixed and embedded. Six-mm-thick sections were processed for
TUNEL staining as described in Materials and methods. Several animals were tested for each experimental condition and similar results
were obtained (see Materials and methods for details). The bar represents 50 mm. 
Discussion
Programmed cell death is essential to remove secretory
epithelial cells from the mammary gland during involu-
tion. The environmental factors that orchestrate this
process are, however, poorly understood. This study in-
vestigated the local effect in the mammary gland of
HAMLET, a folding variant of a-LA bound to oleic acid.
HAMLET was shown to induce a collapse of alveolar
structures (fig. 1) and proteolytic processing of procas-
pase-3 (fig. 2). In addition, HAMLET caused extensive
fragmentation of chromosomal DNA (fig. 3). A weak
apoptotic response to HAMLET was confirmed in vitro
in a cell line derived from secretory epithelial cells. The
effect was specific for HAMLET, as a-LA or oleic acid
were inactive in these assays. The results suggest that
milk constituents might serve as regulators of cellular in-
volution in the mammary gland.
The molecular control of programmed cell death in the
mammary gland has been studied in several systems.
Caspase activation is fundamental to classical apoptosis
and may be triggered by mitochondrial activation or by
ligands binding to members of the Fas tumor necrosis
factor (TNF) receptor family [26, 27]. This latter pathway
is not essential in the mammary gland, however, as shown
in Fas-deficient mice [28]. Still, the involvement of cy-
tochrome c and caspase-3 was independently docu-
mented in SWISS/MORO mice [4], in Balb/c [6, 24] and
in NMRI mice, suggesting that other mechanisms trigger
the mitochondrial response. In Jurkat cells, HAMLET
has been shown to associate with mitochondria and to
trigger cytochrome c release and caspase-3 activation
[19, 29]. The functional importance of the caspase-re-
lated apoptotic response to HAMLET has been ques-
tioned, however, as specific inhibitors like ZVAD did not
inhibit cell death in vitro and overexpression of Bcl-2 did
not rescue tumor cells from HAMLET-induced apoptosis,
and thus the exact role of caspases for HAMLET-induced
cell death in tumor cells needs further study. In the pre-
sent study, in vivo activation of caspase-3 was observed,
and only in tissues exposed to HAMLET. This is consis-
tent with the tumor cell data, but does not prove that the
caspase response is the cause of the morphological
changes observed. 
HAMLET induces apoptosis-like cell death by activation
of several different pathways. One striking feature is the
accumulation of HAMLET in the nuclei of tumor cells
where it binds histones, disrupts chromatin structures and
mediates nuclear DNA fragmentation [18, 29]. Consis-
tent with this mode of action, the present study showed
that HAMLET perturbed the chromatin structure in se-
cretory epithelial cells in the mammary gland and in pro-
liferating cells in culture. Apoptotic cell death during nor-
mal involution was previously shown to result in de novo
expression of several genes, e.g. c-fos, c-jun and cyclin D
that are typically expressed during G1 or during a G1-like
state of the cell cycle. We therefore postulated previously
that a partial dedifferentiation of secretory epithelial cells
occurs before cells die by apoptosis [30]. Not clear
presently is whether exposure to HAMLET initiates a
similar dedifferentiation process before initiation of the
apoptotic process occurs.
If HAMLET can accumulate in milk, and whether the
conditions in the mature mammary gland may permit the
formation of HAMLET from a-LA and oleic acid is not
clear. Normal milk contains a-LA in native conformation
and the physiological conditions required to remove the
calcium and unfold the protein and form the active com-
plex are presently not known. Low pH promotes these
molecular changes. The conditions in the mammary
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Figure 4. Apoptotic cell death of 31D mammary epithelial cells in
response to HAMLET, a-LA or cisplatin (CP). (A) Exponentially
growing cells were treated for 24 h with increasing concentrations
of HAMLET (0.25–2 mg/ml) in the absence of fetal calf serum.
Cells were collected, fixed and at least 300 nuclei were counted af-
ter DAPI staining and the percentage of condensed nuclei was de-
termined. Similarly, condensed nuclei were counted when cells
reached confluence before the addition of HAMLET (H). The 31D
cells were similarly treated with inactive a-LA (a) and cell death
determined after DAPI staining. As controls, proliferating and con-
fluent cells were treated with 10 mg/ml CP. Standard deviations are
shown for several data points. (B) Processing of procaspase-3 and
the presence of active caspase-3 fragments was documented with
the CM1 antibody (a) and DNA fragmentation was visualized after
TUNEL staining in 31D cells treated with 2 mg/ml HAMLET (d).
For comparison, 10 mg/ml CP resulted in CM1-positive cells (b) or
TUNEL-positive nuclei (e). Panels c and f show CM1 and TUNEL
staining of untreated cells.
gland may change during involution, as milk synthesis
ceases only gradually and milk accumulates in alveolar
structures and may be exposed to low pH. Both condi-
tions could favor the formation of a-LA folding interme-
diates and hydrolysis of triglycerides releasing the fatty
acids. Due to the morphological situation in the mam-
mary gland, secretory epithelial cells would be directly
exposed to the milk molecules, thus providing a scenario
where apoptosis of mammary epithelial cells is a self-reg-
ulating process which is induced or supported by milk
components which accumulate in the gland after wean-
ing. Until now, the mechanism by which HAMLET is in-
ternalized is not clear. Sealing of the central duct of a sin-
gle gland has been shown to be sufficient to induce an
apoptotic program exclusively in sealed glands while all
other glands continue to be in a fully lactating state [7,
31], implying that the cell death program can locally
dominate survival signals in the mammary gland. 
Acknowledgements. This work was supported by the Swiss National
Science Foundation (grant 31-61929 to R. J.). C. S. was supported
by grants from the Lund Family American Cancer Society (grant
number, SPG-97-157 CS), The Swedish Cancer Foundation (grant
number, 3807-B97_01XAB CS, 3807-B01-06XCC, 4633-B01-
01XAB1), the Swedish Pediatric Cancer Foundation, The Medical
Faculty, Lund University, The Segerfalk Foundation and The Lund-
gren Foundation for Medical Research, Lund, Sweden. 
1 Ossowski L., Biegel D. and Reich E. (1979) Mammary plas-
minogen activator: correlation with involution, hormonal mod-
ulation and comparison between normal and neoplastic tissue.
Cell. 16: 929–940
2 Feng Z., Marti A., Jehn B., Altermatt H. J., Chicaiza G. and
Jaggi R. (1995) Glucocorticoid and progesterone inhibit invo-
lution and programmed cell death in the mouse mammary
gland. J. Cell Biol. 131: 1095–1103
3 Walker N. I., Bennett R. E. and Kerr J. F. (1989) Cell death by
apoptosis during involution of the lactating breast in mice and
rats. Am. J. Anat. 185: 19–32
4 Strange R., Li F., Saurer S., Burkhardt A. and Friis R. R. (1992)
Apoptotic cell death and tissue remodelling during mouse
mammary gland involution. Development 115: 49–58
5 Boudreau N., Sympson C. J., Werb Z. and Bissell M. J. (1995)
Suppression of ICE and apoptosis in mammary epithelial cells
by extracellular matrix. Science 267: 891–893
6 Marti A., Ritter P. M., Jager R., Lazar H., Baltzer A., Schenkel
J. et al. (2001) Mouse mammary gland involution is associated
with cytochrome c release and caspase activation. Mech. Dev.
104: 89–98
7 Marti A., Feng Z., Altermatt H. J. and Jaggi R. (1997) Milk ac-
cumulation triggers apoptosis of mammary epithelial cells. Eur.
J. Cell Biol. 73: 158–165
8 Li M., Liu X., Robinson G., Bar-Peled U., Wagner K. U., Young
W. S. et al. (1997) Mammary-derived signals activate pro-
grammed cell death during the first stage of mammary gland
involution. Proc. Natl. Acad. Sci. USA 94: 3425–3430
9 Pollard J. W. (2001) Tumour-stromal interactions: transforming
growth factor-beta isoforms and hepatocyte growth factor/scat-
ter factor in mammary gland ductal morphogenesis. Breast
Cancer Res. 3: 230–237
10 Nguyen A. V. and Pollard J. W. (2000) Transforming growth
factor beta3 induces cell death during the first stage of mam-
mary gland involution. Development 127: 3107–3118
11 Marti A., Jehn B., Costello E., Keon N., Ke G., Martin F. et al.
(1994) Protein kinase A and AP-1 (c-Fos/JunD) are induced
during apoptosis of mouse mammary epithelial cells. Onco-
gene 9: 1213–1223
12 Bagheri-Yarmand R., Vadlamudi R. K. and Kumar R. (2003)
Activating transcription factor 4 overexpression inhibits prolif-
eration and differentiation of mammary epithelium resulting in
impaired lactation and accelerated involution. J. Biol. Chem.
278: 17421–17429
13 Groner B. and Hennighausen L. (2000) Linear and cooperative
signaling: roles for Stat proteins in the regulation of cell sur-
vival and apoptosis in the mammary epithelium. Breast Cancer
Res. 2: 149–153
14 Schere-Levy C., Buggiano V., Quaglino A., Gattelli A., Cirio
M. C., Piazzon I. et al. (2003) Leukemia inhibitory factor in-
duces apoptosis of the mammary epithelial cells and partici-
pates in mouse mammary gland involution. Exp. Cell Res. 282:
35–47
15 Permyakov E. A. and Berliner L. J. (2000) Alpha-lactalbumin:
structure and function. FEBS Lett. 473: 269–274
16 Rao K. R. and Brew K. (1989) Calcium regulates folding and
disulfide-bond formation in alpha-lactalbumin. Biochem. Bio-
phys. Res. Commun. 163: 1390–1396
17 Svensson M., Hakansson A., Mossberg A., Linse S. and 
Svanborg C. (2000) Conversion of alpha-lactalbumin to a pro-
tein inducing apoptosis. Proc. Natl. Acad. Sci. USA 97: 4221–
4226
18 Svanborg C., Agerstam H., Aronson A., Bjerkvig R., Duringer
C., Fischer W. et al. (2003) HAMLET kills tumor cells by an
apoptosis-like mechanism – cellular, molecular, and therapeu-
tic aspects. Adv. Cancer Res. 88: 1–29
19 Kohler C., Gogvadze V., Hakansson A., Svanborg C., Orrenius
S. and Zhivotovsky B. (2001) A folding variant of human alpha-
lactalbumin induces mitochondrial permeability transition in
isolated mitochondria. Eur. J. Biochem. 268: 186–191
20 Hakansson A., Zhivotovsky B., Orrenius S., Sabharwal H. and
Svanborg C. (1995) Apoptosis induced by a human milk pro-
tein. Proc. Natl. Acad. Sci. USA 92: 8064–8068
21 Svensson M., Sabharwal H., Hakansson A., Mossberg A. K.,
Lipniunas P., Leffler H. et al. (1999) Molecular characterization
of alpha-lactalbumin folding variants that induce apoptosis in
tumor cells. J. Biol. Chem. 274: 6388–6396
22 Reichmann E., Ball R., Groner B. and Friis R. R. (1989) New
mammary epithelial and fibroblastic cell clones in coculture
form structures competent to differentiate functionally. J. Cell
Biol. 108: 1127–1138
23 Srinivasan A., Roth K. A., Sayers R. O., Shindler K. S., Wong
A. M., Fritz L. C. et al. (1998) In situ immunodetection of acti-
vated caspase-3 in apoptotic neurons in the developing nervous
system. Cell Death Differ. 5: 1004–1016
24 Jäger R., Herzer U., Schenkel J. and Weiher H. (1997) Over-
expression of Bcl-2 inhibits alveolar cell apoptosis during 
involution and accelerates c-myc-induced tumorigenesis of 
the mammary gland in transgenic mice. Oncogene 15: 1787–
1795
25 Doppler W., Groner B. and Ball R. K. (1989) Prolactin and glu-
cocorticoid hormones synergistically induce expression of
transfected rat b-casein gene promoter constructs in a mam-
mary epithelial cell line. Proc. Natl. Acad. Sci. USA 86: 104–
108
26 Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis.
Science 281: 1309–1312
27 Ashe P. C. and Berry M. D. (2003) Apoptotic signaling cas-
cades. Prog. Neuropsychopharmacol. Biol. Psychiatry 27:
199–214
28 Marti A., Graber H., Lazar H., Ritter P. M., Baltzer A., Srini-
vasan A. et al. (2000) Caspases: decoders of apoptotic signals
during mammary involution. Adv. Exp. Biol. Med. 480: 195–
201
CMLS, Cell. Mol. Life Sci. Vol. 61, 2004 Research Article 1227
29 Kohler C., Hakansson A., Svanborg C., Orrenius S. and Zhivo-
tovsky B. (1999) Protease activation in apoptosis induced by
MAL. Exp. Cell Res. 249: 260–268
30 Marti A., Feng Z., Jehn B., Djonov V., Chicaiza G., Altermatt H.
J. et al. (1995) Expression and activity of cell cycle regulators
during proliferation and programmed cell death in the mam-
mary gland. Cell Death Differ. 2: 277–283
31 Talhouk R. S., Bissell M. J. and Werb Z. (1992) Coordinated 
expression of extracellular matrix-degrading proteinases and
their inhibitors regulates mammary epithelial function during
involution. J. Cell Biol. 118: 1271–1282
1228 A. Baltzer, C. Svanborg and R. Jaggi In vivo apoptosis by HAMLET
